Plunkett's Biotech & Genetics Industry Almanac 2013: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies

• Publication date: August 2012
• Report size: 537 pages

PLUNKETT'S BIOTECH & GENETICS INDUSTRY ALMANAC 2013 Key Features: -Industry trends analysis, market data and competitive intelligence -Market forecasts and Industry Statistics -Industry Associations and Professional Societies List -In-Depth Profiles of hundreds of leading companies -Industry Glossary -Buyer may register for access to search and export data at Plunkett Research Online Pages: 537 Statis...

PLUNKETT'S BIOTECH & GENETICS INDUSTRY ALMANAC 2013

Key Features:

-Industry trends analysis, market data and competitive intelligence
-Market forecasts and Industry Statistics
-Industry Associations and Professional Societies List
-In-Depth Profiles of hundreds of leading companies
-Industry Glossary
-Buyer may register for access to search and export data at Plunkett Research Online

Pages: 537
Statistical Tables Provided: 18
Companies Profiled: 353
Geographic Focus: Global

A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms. You will gain vital insights that can help you shape your own strategy for business development, product development and investments.
-How is the industry evolving?
-How is the industry being shaped by new technologies?
-How is demand growing in emerging markets and mature economies?
-What is the size of the market now and in the future?
-What are the financial results of the leading companies?
-What are the names and titles of top executives?
-What are the top companies and what are their revenues?

Contents, Statistics, Forecasts and Analysis Include:

Major Trends Affecting the Biotech & Genetics Industry
1) The State of the Biotechnology Industry Today
2) A Short History of Biotechnology
3) Ethanol Production Soars, But U.S. Federal Subsidy in Question
4) Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms
5) From India to Singapore to China, Nations Compete Fiercely in Biotech Development
6) Clinical Trials and Medical Records Processing Conducted Abroad Spark Concerns
7) Gene Therapies and Patients’ Genetic Profiles Promise a Personalized Approach to Medicine
8) Breakthrough Drugs for Cancer Treatment—Many More Will Follow
9) Few New Blockbusters: Major Drug Patents Expire While Generic Sales Growth Continues
10) Biotech and Orphan Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age
11) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce
12) Breakthrough New Drug Delivery Systems Evolve
13) Stem Cells—Multiple Sources Stem from New Technologies
14) Government Support for Stem Cell Research Evolves
15) Stem Cells—Therapeutic Cloning Techniques Advance
16) Stem Cells—A New Era of Regenerative Medicine Takes Shape
17) Nanotechnology Converges with Biotech
18) Agricultural Biotechnology Scores Breakthroughs but Causes Controversy/Selective Breeding Offers a Compromise
19) Focus on Vaccines
20) Technology Discussion—Genomics
21) Technology Discussion—Proteomics
22) Technology Discussion—Microarrays
23) Technology Discussion—DNA Chips
24) Technology Discussion—SNPs (“Snips”)
25) Technology Discussion—Combinatorial Chemistry
26) Technology Discussion—Synthetic Biology
27) Technology Discussion—Recombinant DNA
28) Technology Discussion—Polymerase Chain Reaction (PCR)

Biotech & Genetics Industry Statistics

1) Biotech Industry Overview
2) The U.S. Drug Discovery & Approval Process
3) U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2011
4) U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals:1993-2011
5) Employment in Life & Physical Science Occupations, U.S.: May 2011
6) Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2011-2013
7) U.S. Exports & Imports of Pharmaceutical Products: 2007-1st Quarter 2012
8) U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: 2006-2021
9) U.S. Prescription Drug Expenditures: 1970-2021
10) Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2011
11) Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2011-2013
12) Global Area of Biotech Crops by Country: 2011
13) Biologics & Biotechnology R&D, PhRMA Member Companies: 2010
14) Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1975-2011
15) Sales By Geographic Area, PhRMA Member Companies: 2010
16) Domestic U.S. Biopharmaceutical R&D Breakdown, PhRMA Member Companies: 2010
17) Domestic Biopharmaceutical R&D Scientific, Professional & Technical Personnel by Function, PhRMA Member Companies: 2010
18) Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1975-2011

Genomics Industry in the United States

Table of Contents
PLUNKETT’S BIOTECH & GENETICS
INDUSTRY ALMANAC 2013
CONTENTS
A Short Biotech & Genetics Industry Glossary x
Introduction 1
How to Use This Book 3
Chapter 1: Major Trends Affecting the Biotech & Genetics Industry 7
1) The State of the Biotechnology Industry Today 8
2) A Short History of Biotechnology 13
3) Ethanol Production Soars, But U.S. Federal Subsidy in Question 14
4) Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms 17
5) From India to Singapore to China, Nations Compete Fiercely in Biotech Development 18
6) Clinical Trials and Medical Records Processing Conducted Abroad Spark Concerns 20
7) Gene Therapies and Patients’ Genetic Profiles Promise a Personalized Approach to
Medicine 21
8) Breakthrough Drugs for Cancer Treatment—Many More Will Follow 24
9) Few New Blockbusters: Major Drug Patents Expire While Generic Sales Growth Continues 25
10) Biotech and Orphan Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age 27
11) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/
Competition Will Be Fierce 28
12) Breakthrough New Drug Delivery Systems Evolve 30
13) Stem Cells—Multiple Sources Stem from New Technologies 30
14) Government Support for Stem Cell Research Evolves 32
15) Stem Cells—Therapeutic Cloning Techniques Advance 33
16) Stem Cells—A New Era of Regenerative Medicine Takes Shape 35
17) Nanotechnology Converges with Biotech 37
18) Agricultural Biotechnology Scores Breakthroughs but Causes Controversy/Selective
Breeding Offers a Compromise 38
19) Focus on Vaccines 41
20) Technology Discussion—Genomics 42
21) Technology Discussion—Proteomics 42
22) Technology Discussion—Microarrays 43
23) Technology Discussion—DNA Chips 43
24) Technology Discussion—SNPs (“Snips”) 44
25) Technology Discussion—Combinatorial Chemistry 44
26) Technology Discussion—Synthetic Biology 44
27) Technology Discussion—Recombinant DNA 45
28) Technology Discussion—Polymerase Chain Reaction (PCR) 45
Chapter 2: Biotech & Genetics Industry Statistics 46
Biotech Industry Overview 47
The U.S. Drug Discovery & Approval Process 48
U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2011 49
U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME)
Approvals:1993-2011 50
Employment in Life & Physical Science Occupations, U.S.: May 2011 51
Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.:
Fiscal Years 2011-2013 52
U.S. Exports & Imports of Pharmaceutical Products: 2007-1st Quarter 2012 53
U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution:
2006-2021 54
U.S. Prescription Drug Expenditures: 1970-2021 56
Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2011 58
Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years
2011-2013 59
Global Area of Biotech Crops by Country: 2011 60
Biologics & Biotechnology R&D, PhRMA Member Companies: 2010 61
Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1975-2011 62
Sales By Geographic Area, PhRMA Member Companies: 2010 63
Domestic U.S. Biopharmaceutical R&D Breakdown, PhRMA Member Companies: 2010 64
Domestic Biopharmaceutical R&D Scientific, Professional & Technical Personnel by Function,
PhRMA Member Companies: 2010 65
Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1975-2011 66
Chapter 3: Important Biotech & Genetics Industry Contacts 67
(Addresses, Phone Numbers and Internet Sites)
Chapter 4: THE BIOTECH 350:
Who They Are and How They Were Chosen 106
Industry List, With Codes 107
Index of Companies Within Industry Groups 108
Alphabetical Index 116
Index of U.S. Headquarters Location by State 119
Index of Non-U.S. Headquarters Location by Country 122
Index by Regions of the U.S. Where the Firms Have Locations 124
Index by Firms with International Operations 130
Individual Profiles on Each of THE BIOTECH 350 132
Additional Indexes
Index of Hot Spots for Advancement for Women/Minorities 487
Index by Subsidiaries, Brand Names and Selected Affiliations 489
Companies Mentioned
23AndMe Inc
3SBio Inc
4SC AG
Aastrom Biosciences Inc
Abaxis Inc
Abbott Laboratories
Accelrys Inc
Access Pharmaceuticals Inc
Actelion Ltd
Adamis Pharmaceuticals Corporation
Adolor Corp
Advanced Cell Technology Inc
Advanced Life Sciences Holdings Inc
AdvanSource Biomaterials Corporation
Aeolus Pharmaceuticals Inc
AEterna Zentaris Inc
Affymetrix Inc
Agenus Inc
Agilent Technologies Inc
Akorn Inc
Albany Molecular Research Inc
Alcon Inc
Aldagen Inc
Alexion Pharmaceuticals Inc
Alimera Sciences Inc
Alkermes plc
Allergan Inc
Alliance Pharmaceutical Corp
Allos Therapeutics Inc
Alseres Pharmaceuticals Inc
Amarin Corporation plc
Amgen Inc
AmpliPhi Biosciences Corporation
Amylin Pharmaceuticals Inc
Amyris Biotechnologies Inc
Anacor Pharmaceuticals Inc
Angiotech Pharmaceuticals Inc
Anika Therapeutics Inc
APP Pharmaceuticals Inc
Applied Molecular Evolution Inc
Apricus Biosciences Inc
Aptalis Pharma
Aradigm Corporation
Arcadia Biosciences Inc
Arena Pharmaceuticals Inc
Ariad Pharmaceuticals Inc
ArQule Inc
Array BioPharma Inc
Arryx Inc
Astellas Pharma Inc
Astex Pharmaceuticals Inc
AstraZeneca Canada
AstraZeneca plc
Avanir Pharmaceuticals
AVAX Technologies Inc
AVIVA Biosciences Corp
BASF SE
Bausch & Lomb Inc
Baxter International Inc
Bayer AG
Bayer Corp
Bayer Healthcare Pharmaceuticals
BIND Biosciences Inc
Bio Rad Laboratories Inc
Bioanalytical Systems Inc
Biocancell Therapeutics Inc
Biocompatibles International Ltd
BioCryst Pharmaceuticals Inc
Biogen IDEC Inc
Bioheart Inc
BioMarin Pharmaceutical Inc
Biomet Inc
BioNano Genomics
BioReliance Corp
Biosite Inc
BioTime Inc
BrachyTherapy Services Inc
Bristol-Myers Squibb Co
BroadSoft Inc
Burrill & Company
Caliper Life Sciences Inc
Cambrex Corp
Cangene bioPharma Inc
Cangene Corp
Caraco Pharmaceutical Laboratories Ltd
Cardiome Pharma Corp
Cardium Therapeutics Inc
Cegedim SA
Celera Corporation
Celgene Corp
Cell Therapeutics Inc
Cellartis AB
Celldex Therapeutics Inc
Cellular Dynamics International
CEL-SCI Corporation
Celsis International plc
Cephalon Inc
Cepheid
Cerus Corporation
Charles River Laboratories International Inc
Claros Diagnostics Inc
CML Healthcare Inc
Columbia Laboratories Inc
Complete Genomics Inc
Compugen Ltd
Cortex Pharmaceuticals Inc
Covance Inc
Covidien plc
Crucell NV
CSL Limited
Cubist Pharmaceuticals Inc
Cumberland Pharmaceuticals Inc
Curis Inc
CytRx Corporation
Daiichi Sankyo Co Ltd
Dainippon Sumitomo Pharma Co Ltd
deCODE genetics Ltd
Dendreon Corporation
Depomed Inc
diaDexus Inc
Discovery Laboratories Inc
Divi's Laboratories Limited
D-Medical Industries Ltd
Dow AgroSciences LLC
Dr Reddy's Laboratories Limited
DSM Pharmaceutical Products Inc
DuPont (E I du Pont de Nemours & Co)
DuPont Agriculture & Nutrition
Durect Corp
DUSA Pharmaceuticals Inc
Dyax Corp
Eisai Co Ltd
Elan Corp plc
Eli Lilly & Company
Emisphere Technologies Inc
Encorium Group Inc
Endo Health Solutions Inc
EntreMed Inc
Enzo Biochem Inc
Enzon Pharmaceuticals Inc
Epizyme
eResearch Technology Inc
EUSA Pharma (USA) Inc
Evotec AG
Exelixis Inc
Flamel Technologies SA
Forest Laboratories Inc
Galderma Pharma SA
GE Healthcare
Genencor International Inc
Genentech Inc
Generex Biotechnology Corporation
GenMark Diagnostics Inc
Genocea Biosciences
Genomic Health Inc
Gen-Probe Inc
Genta Inc
GenVec Inc
Genzyme Biosurgery
Genzyme Corp
Genzyme Oncology
Geron Corporation
Gilead Sciences Inc
GlaxoSmithKline plc
GTC Biotherapeutics Inc
Harbor BioSciences Inc
Harvard Bioscience Inc
Hemagen Diagnostics Inc
Hemispherx Biopharma Inc
Heska Corp
Hi-Tech Pharmacal Co Inc
Hospira Inc
Human Genome Sciences Inc
Hycor Biomedical Inc
I3 CanReg Inc
ICON plc
Idera Pharmaceuticals Inc
IDEXX Laboratories Inc
Illumina Inc
ImClone Systems Inc
Immtech Pharmaceuticals Inc
ImmuCell Corporation
ImmunoGen Inc
Immunomedics Inc
Immunomedics Inc
IMPAX Laboratories Inc
IMS Health Inc
Incyte Corp
Independence Resources plc
Infinity Pharmaceuticals Inc
InSite Vision Inc
Insmed Inc
Institut Straumann AG
Integra Lifesciences Holdings Corp
IntelliPharmaCeutics International Inc
InterMune Inc
International Isotopes Inc
Ion Torrent
Ironwood Pharmaceuticals Inc
Isis Pharmaceuticals Inc
Jazz Pharmaceuticals plc
Johnson & Johnson
Joule Unlimited Technologies
Jubilant Biosys Ltd
Keryx Biopharmaceuticals Inc
KV Pharmaceutical Co
La Jolla Pharmaceutical Company
Lannett Company Inc
Lexicon Pharmaceuticals Inc
Life Technologies Corp
LifeCell Corporation
Lifecore Biomedical Inc
Ligand Pharmaceuticals Inc
Lonza Group Ltd
Lorus Therapeutics Inc
Luminex Corporation
Marina Biotech Inc
Maxygen Inc
Medicines Co (The)
Medicis Pharmaceutical Corp
Medidata Solutions Inc
Medimmune Inc
MEDTOX Scientific Inc
Merck & Co Inc
Merck KGaA
Merck Serono SA
Meridian Bioscience Inc
Metabolix Inc
Metabolon Inc
Millennium Pharmaceuticals Inc
Millipore Corp
Monsanto Co
Mylan Inc
Myriad Genetics Inc
Myriad RBM
Nabi Biopharmaceuticals
NanoBio Corporation
Navidea Biopharmaceuticals Inc
Nektar Therapeutics
Neogen Corporation
Nordion Inc
Novartis AG
Novavax Inc
Noven Pharmaceuticals Inc
Novo-Nordisk AS
Novozymes
NPS Pharmaceuticals Inc
Nycomed
Obagi Medical Products Inc
OncoGenex Pharmaceuticals Inc
Oncothyreon Inc
Onyx Pharmaceuticals Inc
OraSure Technologies Inc
Orchid Cellmark Inc
Ore Holdings Inc
Organogenesis Inc
OSI Pharmaceuticals LLC
Otsuka Holdings Co Ltd
OXiGENE Inc
Pacific Biosciences of California Inc
Pain Therapeutics Inc
Palatin Technologies Inc
Par Pharmaceutical Companies Inc
PAREXEL International Corp
PDL BioPharma
Peregrine Pharmaceuticals Inc
Perrigo Co
Pfizer Inc
Pharmaceutical Product Development Inc
Pharmacyclics Inc
PharmaNet/i3
Pharmathene Inc
Pharmos Corp
Pharsight Corp
Pioneer Hi-Bred International Inc
Polydex Pharmaceuticals Ltd
Poniard Pharmaceuticals Inc
Pozen Inc
PRA International
Progenics Pharmaceuticals Inc
Promega Corp
Protein Polymer Technologies Inc
QIAGEN NV
QLT Inc
Quest Diagnostics Inc
Questcor Pharmaceuticals Inc
Quintiles Transnational Corp
Ranbaxy Laboratories Limited
Raptor Pharmaceutical Corp
Regeneron Pharmaceuticals Inc
Repligen Corporation
Repros Therapeutics Inc
Rigel Pharmaceuticals Inc
Roche Holding Ltd
S&W Seed Co
Salix Pharmaceuticals
Sangamo BioSciences Inc
Sanofi SA
Sarepta Therapeutics Inc
Savient Pharmaceuticals Inc
SciClone Pharmaceuticals Inc
Scios Inc
Seattle Genetics
Sequenom Inc
SeraCare Life Sciences Inc
Shionogi Inc
Shire Canada Inc
Shire plc
Siemens Healthcare Diagnostics
SIGA Technologies Inc
Sigma-Aldrich Corp
Simcere Pharmaceutical Group
SkyePharma plc
Soligenix Inc
Specialty Laboratories Inc
Spectral Diagnostics Inc
Spectrum Pharmaceuticals Inc
Spherix Inc
StemCells Inc
Stiefel Laboratories Inc
Synageva BioPharma Corp
Synbiotics Corp
Syngenta AG
Synovis Life Technologies Inc
Synthetic Genomics Inc
Takeda Pharmaceutical Company Ltd
Tamir Biotechnology Inc
Taro Pharmaceutical Industries
Techne Corp
Telik Inc
Tengion Inc
Teva Parenteral Medicines Inc
Teva Pharmaceutical Industries Ltd
TG Therapeutics Inc
Theragenics Corp
Thermo Fisher Scientific Inc
Thermo Scientific
Titan Pharmaceuticals Inc
TOLMAR Inc
Toyobo Co Ltd
Trinity Biotech plc
Tripos International
Trius Therapeutics Inc
UCB SA
Unigene Laboratories Inc
United Therapeutics Corp
United-Guardian Inc
Urigen Pharmaceuticals Inc
Valeant Pharmaceuticals International
Ventria Bioscience
Verenium Corporation
Vermillion Inc
Vernalis plc
Vertex Pharmaceuticals Inc
ViaCord Inc
Vical Inc
Virbac Corp
ViroPharma Inc
Vivus Inc
Warner Chilcott plc
Watson Pharmaceuticals Inc
Whatman plc
XDX Inc
XenoPort Inc
XOMA Corporation
ZIOPHARM Oncology Inc
Zogenix Inc
ZymoGenetics Inc